Human Genome

Back in early July, Human Genome Sciences Inc. (HGSI) shares jumped over 230 percent in one day after the pharmaceutical company said its experimental lupus drug had succeeded in a late-stage clinical trial, silencing many of its skeptics. If you decided then that a 230 percent move was all that...

Human Genome Sciences (HGSI) and GlaxoSmithKline (GSK) say their experimental lupus drug passed another key treatment goal and they plan on asking for regulatory approval in the first half of 2010. Wall Street and researchers anticipated study data from Bliss-76, hoping it would confirm positive...

Ford Motor Co. (F) is no doubt this morning's story. The automaker, the only one of the Big Three American car manufacturers that didn't take a direct government bailout and stayed out of bankruptcy protection, reported a surprising $1 billion profit Monday morning. Ford reported net income of $997...